Annexon (ANNX) Tax Provisions (2019 - 2020)
Annexon's (ANNX) quarterly Tax Provisions came in at $10000.0 in Q4 2020, up 225.0% year-on-year from $3076.9 in Q1 2020, and up 900.0% quarter-over-quarter from $1000.0 in Q3 2020.
Annexon (ANNX) Tax Provisions (2019 - 2020) Analysis & Trends
Annexon's Tax Provisions history runs 2 years deep, the most recent figure standing at $10000.0 for Q4 2020.
- On a quarterly basis, Tax Provisions rose 225.0% year-over-year to $10000.0 in Q4 2020; TTM through Dec 2020 was $7000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $15000.0, up 400.0% from the prior year.
- Tax Provisions grew to $10000.0 in Q4 2020 per ANNX's latest filing, from $1000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $10000.0 in Q4 2020 and bottomed at -$8000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 10,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Dec 31, 2019 | -8,000.00 |
| Sep 30, 2019 | 2,000.00 |